Specialize! The development of diagnostic and therapeutic techniques for liver pathologies has turned hepatology into an area of knowledge or specific education that is highly demanded by medical professionals today"

Hepatology has experienced great changes in recent years. There have been important developments in the last 35-40 years, in both diagnostic and treatment techniques. In terms of diagnosis, we have seen the introduction of Ultrasound, Computerized Axial Tomography, Nuclear Magnetic Resonance, FibroScan, etc.

With regard to treatment, we have gone from patiently observing the evolution of liver disease without being able to offer patients anything, to now being able to prescribe effective treatments such as new antivirals for hepatitis B and C, immunosuppressants for autoimmune diseases or liver transplantation for end-stage liver disease.

All this has meant that Hepatology today constitutes a specific area of knowledge, which sometimes exceeds the objectives of the digestive system specialists' education period, thereby implying the need for professional development and the existence of skilled professionals.

It is essential that specialists can respond adequately to the evolution of these events, through an adequate update of their knowledge and the incorporation of these advances in their daily medical practice, which is why TECH has developed this comprehensive program in response to an in-demand specialty.

You will learn in depth about the advances made in the diagnosis and treatment of viral hepatitis, the recognition of new liver pathologies and the generalization of liver transplantation" 

The Master's Degree in Hepatology contains the most complete and updated scientific program on the market. The most important features of the program include:

• More than 80 clinical cases, presented by experts in the different specialties. The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• New diagnoses and treatments for different hepatic pathologies
• Presentation of practical workshops on procedures, diagnosis, and treatment techniques
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• Special emphasis on evidence-based medicine and research methodologies in the field of hepatology
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Master's Degree may be the best investment you can make when choosing a refresher program for two reasons: in addition to updating your knowledge in Hepatology, you will obtain a Master's Degree from TECH Global University"

The program’s teaching staff includes a team of healthcare professionals, who bring their experience to this training program, as well as renowned specialists from leading scientific societies.

The multimedia content, developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training, programmed for training in real situations.

This program is designed around Problem Based Learning, whereby the physician must try to solve the different professional practice situations that arise during the course. For this purpose, the specialist will be assisted by an innovative interactive video system created by renowned and experienced experts in treating patients with hepatic pathology with extensive teaching experience.

Increase your decision-making confidence by updating your knowledge through this Master's Degree"

Make the most of the opportunity and choose to stay up to date, to improve your medical practice with your patients"

The structure of the contents has been designed by a team of professionals who recognise the implications of medical training in treating patients with liver diseases, are aware of the relevance of current training, and are committed to quality teaching using new educational technologies.

This Master's Degree in Hepatology will allow you to expand your knowledge and improve the medical practice as you treat your patients"

Module 1. Diagnostic Methods and Research Techniques 

1.1. Introduction to the Diagnostic Methods. Hepatic function and prognoses
1.2. Hepatic biopsy
1.3. Non-Invasive Methods for Assessing Hepatic Fibrosis
1.4. Diagnostic Imaging: Ultrasound, CT, MRI, MRI
1.5. Basic and Advanced Endoscopy
1.6. Introduction to Research Techniques in Hepatology
1.7. Animal and Cellular Models
1.8. Immunological Techniques
1.9. PCR Techniques: Conventional and Point-of-Diagnosis
1.10. Next-Generation Sequencing Techniques: NGS

Module 2. Viral Hepatitis 

2.1. Hepatitis A
2.2. Hepatitis B (Epi, Natural History and Diagnosis)
2.3. Hepatitis B (Treatment)
2.4. Hepatitis B (Special Populations)
2.5. Hepatitis D
2.6. Hepatitis C (Epi, Natural History and Diagnosis)
2.7. Hepatitis C (Treatment)
2.8. Hepatitis C (Special Populations)
2.9. Hepatitis E
2.10. Other Viral Hepatitis

Module 3. Autoimmune Hepatitis and Cholangitis 

3.1. HAI (Pathogenesis and Diagnostic Criteria)
3.2. HAI (Treatment)
3.3. HAI (Treatment in Non-Responders or Intolerant Patients)
3.4. HAI vs. DILI: Immune-Mediated Hepatitis
3.5. Intrahepatic and Extrahepatic Cholestasis: Differential DX
3.6. Primary Biliary Cholangitis (PBC): Pathogenesis and DX
3.7. PBC: Treatment
3.8. Primary Sclerosing Cholangitis (PSC): Pathogenesis, Symptoms and Diagnosis
3.9. CEP (Treatment)
3.10. Overlap Syndromes

Module 4. Alcoholic Liver Disease and Metabolic Hepatic Steatosis

4.1. Alcoholic Liver Disease (ALD): EPI, Natural History Clinical Manifestations
4.2. ALD: Diagnosis and Severity Assessment
4.3. Acute Hepatitis
4.4. Cirrhosis
4.5. Liver Transplantation in ALD
4.6. Metabolic Hepatic Steatosis (MetHSS): Definition, Epi and Natural History
4.7. MetHSS: Pathogenesis and Role of the Intestinal Microbiota
4.8. MetHSS: Diagnosis
4.9. METHss: Treatment
4.10. Liver Cancer and Transplantation in MetHSS

Module 5. Hepatic Cirrhosis I

5.1. Definition, Pathophysiology, Natural History
5.2. Clinical Manifestations and Prognostic Models
5.3. Compensated and Decompensated Cirrhosis
5.4. Use of Medication in Cirrhotic Patients
5.5. Nutrition in Cirrhosis
5.6. Portal Hypertension
5.7. Ascites
5.8. Renal Failure in Cirrhosis: Classification, Diagnosis and Biomarkers
5.9. Treatment of Renal Insufficiency and Hepatorenal Syndrome 
5.10. The Role of Albumin in the Treatment of Cirrhotic Patients

Module 6. Hepatic Cirrhosis II 

6.1. Upper Gastrointestinal Bleeding (UGH) Secondary to Portal Hypertension 
6.2. TIPS: Current Indications
6.3. Hepatic Encephalopathy (HE): Concept, Pathogenesis and Symptoms. Minimum HE
6.4. HE: Treatment
6.5. Pulmonary Pathology in Cirrhosis: Hepatopulmonary Syndrome
6.6. Pulmonary Pathology in Cirrhosis: Porto-Pulmonary Hypertension
6.7. Acute on Chronic Hepatic Failure
6.8. Cardiomyopathy of the Cirrhotic Patient
6.9. Spontaneous Bacterial Peritonitis
6.10. Others Infections in the Cirrhotic Patient

Module 7. Other Metabolic Liver Diseases

7.1. Hemochromatosis: EPI and Clinical Manifestations
7.2. Hemochromatosis: DX and Treatment
7.3. Hemochromatosis Due to Non-Classical Genes
7.4. Liver Porphyrias
7.5. Wilson’s Disease: EPI and Clinical Manifestations
7.6. Wilson’s Disease: Diagnosis
7.7. Wilson Disease: Treatment 
7.8. Deficiency of Alfa1 Antitripsina
7.9. LPAC
7.10. Glycogenosis

Module 8. Liver Tumors

8.1. Epidemiology, Risk Factors and Screening for Hepatocellular Carcinoma 
8.2. Diagnosis, Prognostic Evaluation and Staging of HCC
8.3. Hepatic Resection of HCC
8.4. Ablative HCC Treatments
8.5. Transarterial HCC Treatments
8.6. Liver Transplantation and HCC
8.7. Systemic Treatment and HCC. Basic Concepts, Immunotherapy and Antiangiogenesis
8.8. Future Perspectives in HCC Management
8.9. Cholangiocarcinoma
8.10. Benign Hepatic Tumors

Module 9. Liver Transplant

9.1. Indications, Patient Selection, and Waiting List Management
9.2. Expansion of Liver Transplant Criteria. Organ Preservation Strategies
9.3. Severe Acute Liver Failure
9.4. Liver Transplant Surgery
9.5. Infections and Liver Transplantation
9.6. Immunosuppression in Liver Transplantation. Acute and Chronic Rejection
9.7. Biliary Complications
9.8. Long-Term Management of Transplanted Patients
9.9. Hepatocarcinoma and De Novo Tumors After Liver Transplantation
9.10. Survival in Liver Transplantation. Factors Associated with Early and Late Mortality

Module 10. Miscellaneous: Hepatic Vascular Diseases, Hepatotoxicity, Hepatic Pathology in Pregnancy

10.1. Non-Cirrhotic Portal Hypertension
10.2. Budd-Chiari Syndrome
10.3. Portal Vein Thrombosis in Cirrhosis Patients
10.4. Portal Vein Thrombosis in Non-Cirrhosis Patients
10.5. Sinusoidal Obstruction Syndrome
10.6. DILI 
10.7. Surgical Risk Assessment in Cirrhosis Patients
10.8. Fontan-associated L

A unique, key, and decisive training experience to boost your professional development"